SFC Capital's Biotechnology Portfolio

Cellestial Health is a preclinical biopharmaceutical company.

PREMAZ is a health tech company providing a digital cognitive assessment tool for early detection and monitoring of subtle memory change.

4D Medicine specializes in bioresorbable polymers and medical device solutions, focusing on materials for 3D-printed implants.

Evolutor provides proprietary technology and microbiology to unlock the potential of evolution beyond current possibilities.

Corryn is a biotechnology company that develops wound dressing devices to redefine the chronic and complex wound care.

BIOVIT develops fortified foods using 100% organic plant extracts which are naturally high in vitamins and minerals.

Avigen is a research orriented firm discovering drugs to accelerate immune cell development.

Pathfinder Bio designs and develops optimum enzyme based biomanufacturing processes for sustainable chemical manufacturing.

Impulsonics uses acoustic waves to streamline biotech automation and create unique capabilities in cell and tissue engineering.

Consone AI a disruptive technology platform targeting decisions that are made in the drug development process.

Myomaker Bio develops lab-grown human skeletal muscle platforms for preclinical drug testing.

PulmoBiomed provide clinicians and researchers a non-invasive means of sampling fluids.

Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines and therapeutics into fridge free thermostable products.

PlantSea manufactures and develops sustainable products using seaweed and aquaculture materials.

Reagent manufacturers and inventors of PurifAI

Deep Blue Biotech uses synthetic biology to decarbonize chemicals, aiming for sustainable solutions to combat the climate crisis.

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.

Biomarx specializes in automated genomic diagnostics.

VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.

Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.

ReNewVax develops pneumococcal vaccines to prevent life-threatening bacterial infections.

RS & RS Scientific focuses on biotech research for innovative cancer therapies, including inhalable gene treatments for lung cancer.

Verinnogen is a biotechnology company that works in pre-clinical cancer research and medical devices.